These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23725709)

  • 61. Lung Resection in the Postpneumonectomy Patient.
    Asai M; Scott WJ
    Thorac Surg Clin; 2018 Feb; 28(1):19-25. PubMed ID: 29150034
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Early diagnosis pivotal to survival in lung cancer.
    O'Dowd EL; Baldwin DR
    Practitioner; 2014 Nov; 258(1776):21-4, 2-3. PubMed ID: 25597199
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stereotactic ablative radiotherapy and surgery: two gold standards for early-stage non-small cell lung cancer?
    Chen H; Louie AV
    Ann Transl Med; 2015 Jun; 3(9):113. PubMed ID: 26207241
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new era of thoracic oncology? Ex-vivo stereotactic ablative radiosurgery within Ex-vivo Lung Treatment System as a hybrid therapy for unresectable locally advanced pulmonary malignancies.
    Henkenberens C; Zinne N; Biancosino C; Höffler K; Schmitto JD; Bremer M; Haverich A; Krüger M
    Med Hypotheses; 2016 Jul; 92():31-4. PubMed ID: 27241251
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stereotactic Radiotherapy Versus Surgery for Early-Stage Operable Lung Cancer: More Questions Than Answers.
    Verma V
    J Natl Compr Canc Netw; 2015 Oct; 13(10):1293-5. PubMed ID: 26483066
    [No Abstract]   [Full Text] [Related]  

  • 66. Lung Cancer Screening and Its Impact on Surgical Volume.
    Dhanasopon AP; Kim AW
    Surg Clin North Am; 2017 Aug; 97(4):751-762. PubMed ID: 28728713
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a word of caution.
    Varela G; Gómez-Hernández MT
    Transl Lung Cancer Res; 2016 Feb; 5(1):102-5. PubMed ID: 26958502
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Lung Excision for Clinical Stage I Lung Cancer].
    Sawabata N; Matsutani N; Kawase A; Takahashi N
    Kyobu Geka; 2016 Sep; 69(10):838-42. PubMed ID: 27586314
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Advances in Diagnosis and Treatment of Multiple Primary Lung Cancer].
    Luo W; Zhou P; Li W
    Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):640-3. PubMed ID: 26483337
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The year in thoracic surgery: highlights from 2014.
    Weyant MJ
    Semin Cardiothorac Vasc Anesth; 2015 Mar; 19(1):24-8. PubMed ID: 25667305
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Creating a Sustainable Future of Radiotherapy Following COP26: A Case for Lung Stereotactic Ablative Radiotherapy Over Surgery?
    Stanford-Edwards C; Edwards M; Selby A; Lewis R; Powell C; Nicholas O
    Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):e105-e106. PubMed ID: 34895991
    [No Abstract]   [Full Text] [Related]  

  • 72. It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible.
    Brunelli A
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1247-1248. PubMed ID: 29754789
    [No Abstract]   [Full Text] [Related]  

  • 73. Minimally Invasive Surgery for Early-Stage Lung Cancer: From Innovation to Standard of Care.
    White A; Swanson SJ
    Oncology (Williston Park); 2016 Nov; 30(11):982-7. PubMed ID: 27854099
    [TBL] [Abstract][Full Text] [Related]  

  • 74. On-Treatment Verification for Lung Stereotactic Ablative Radiation Therapy.
    Barrett S
    J Med Imaging Radiat Sci; 2017 Dec; 48(4):343-345. PubMed ID: 31047468
    [No Abstract]   [Full Text] [Related]  

  • 75. Immunomodulatory effect of stereotactic ablative radiotherapy in lung cancer.
    Domagała-Kulawik J
    Pol Arch Intern Med; 2017 Apr; 127(4):233-234. PubMed ID: 28452968
    [No Abstract]   [Full Text] [Related]  

  • 76. Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy.
    Siva S; Senan S; Ball D
    Ann Oncol; 2015 Oct; 26(10):2196. PubMed ID: 26156078
    [No Abstract]   [Full Text] [Related]  

  • 77. The best that surgery has to offer.
    D'Amico TA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):699-701. PubMed ID: 23312096
    [No Abstract]   [Full Text] [Related]  

  • 78. Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al.
    de Baère T; Aupérin A; Deschamps F; Chevallier P; Gaubert Y; Boige V; Fonck M; Escudier B; Palussiére J
    Ann Oncol; 2015 Oct; 26(10):2196-7. PubMed ID: 26193885
    [No Abstract]   [Full Text] [Related]  

  • 79. Lung Cancer in the Older Patient.
    Barta JA; Zinner RG; Unger M
    Clin Geriatr Med; 2017 Nov; 33(4):563-577. PubMed ID: 28991651
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Cooperation between radiologists and surgeons in the treatment of pulmonary cancer].
    TOPOL O
    Cas Lek Cesk; 1961 Sep; 100():1138-41. PubMed ID: 13921909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.